EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin‐Isatin Hybrids as Potent Anti‐Breast Cancer Agents

Zhi Xu, Xiaoyan Zhang, Jie Liu, Shijia Zhao, Junna Liu, Wei Zhou

Chemistry & Biodiversity · 2023

DOI: 10.1002/cbdv.202201257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Zhi Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, P. R. China. Hauptthemen laut MEDLINE: Isatin, Antineoplastic Agents, Artemisinins, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Important Field Project of Guizhou of Education, Guizhou Provincial Health Commission, Guizhou Provincial Science and Technology Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel amyl ester tethered dihydroartemisinin‐isatin hybrids 4a–d and 5a–h were designed, synthesized, and evaluated as anti‐breast cancer agents. The synthesized hybrids were preliminarily screened against estrogen receptor‐positive (MCF‐7 and MCF‐7/ADR) and triple‐negative (MDA‐MB‐231 and) breast cancer cell lines. Three hybrids 4a , d and 5e not only were more potent than artemisinin and adriamycin against drug‐resistant MCF‐7/ADR and MDA‐MB‐231/ADR breast cancer cell lines, but also displayed non‐cytotoxicity towards normal MCF‐10 A breast cells, and the SI values were >4.15, indicating their excellent selectivity and safety profiles. Thus, hybrids 4a , d and 5e could act as potential anti‐breast cancer candidates and were worthy of further preclinical evaluations. Moreover, the structure–activity relationships which may facilitate further rational design of more effective candidates were also enriched.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsatinAntineoplastic AgentsArtemisininsBreast NeoplasmsHumansFemaleStructure-Activity RelationshipCell Line, TumorMolecular StructureCell ProliferationDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

breast cancerdihydroartemisinindrug resistancehybrid moleculesisatin

Substanzen

artenimolIsatinAntineoplastic AgentsArtemisinins

Autor:innen und Institutionen

  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, P. R. China.
  • Department of Pharmacology, School of Medical Sciences, Guizhou Medical University, Guiyang, 550025, Guizhou, P. R. China.
  • Department of Pharmaceutical Analysis, School of Pharmacy, Guizhou Medical University, Guiyang, 550025, Guizhou, P. R. China.
  • School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan, 430081, P. R. China.

Förderung

  • Important Field Project of Guizhou of Education
  • Guizhou Provincial Health Commission
  • Guizhou Provincial Science and Technology Support
  • Guizhou Provincial
  • Health Commission of Guizhou Province

Zitieren

APA

Xu, Z., Zhang, X., Liu, J., Zhao, S., Liu, J., & Zhou, W. (2023). Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin‐Isatin Hybrids as Potent Anti‐Breast Cancer Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202201257

Vancouver

Xu Z, Zhang X, Liu J, Zhao S, Liu J, Zhou W. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin‐Isatin Hybrids as Potent Anti‐Breast Cancer Agents. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202201257

BibTeX
@article{Xu2023,
  author = {Xu, Zhi and Zhang, Xiaoyan and Liu, Jie and Zhao, Shijia and Liu, Junna and Zhou, Wei},
  title = {Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin‐Isatin Hybrids as Potent Anti‐Breast Cancer Agents},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  doi = {10.1002/cbdv.202201257}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche